Sodium Hyaluronate 1.2%
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Sodium Hyaluronate 1.2%, covering 2012-06-04 to 2012-06-04. Get the full timeline:
Most recent: Clinical Trial Update: Investigation of 1.2% Sodium Hyaluronate for Treatment of Painful Chronic Osteoarthritis of the Knee [Phase 3]